Institutional investors purchased a net $863.9 thousand shares of ICLR during the quarter ended December 2017 and now own 95.49% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
RENAISSANCE TECHNOLOGIES LLC Bought 495.2 Thousand shares of ICON PLC
ROBERT W. BAIRD & CO., INC. (EQU... Bought 303.5 Thousand shares of ICON PLC
WCM INVESTMENT MANAGEMENT Bought 234.0 Thousand shares of ICON PLC